VRTX vs. LNTH
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and Lantheus Holdings, Inc. (LNTH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or LNTH.
Correlation
The correlation between VRTX and LNTH is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
VRTX vs. LNTH - Performance Comparison
Loading data...
Key characteristics
VRTX:
-0.06
LNTH:
0.00
VRTX:
0.17
LNTH:
0.59
VRTX:
1.02
LNTH:
1.09
VRTX:
-0.02
LNTH:
0.10
VRTX:
-0.04
LNTH:
0.18
VRTX:
9.00%
LNTH:
20.08%
VRTX:
28.47%
LNTH:
65.41%
VRTX:
-91.77%
LNTH:
-78.62%
VRTX:
-18.50%
LNTH:
-36.25%
Fundamentals
VRTX:
$110.94B
LNTH:
$5.46B
VRTX:
-$3.82
LNTH:
$3.51
VRTX:
2.57
LNTH:
0.61
VRTX:
9.99
LNTH:
3.55
VRTX:
6.72
LNTH:
4.69
VRTX:
$11.09B
LNTH:
$1.54B
VRTX:
$9.54B
LNTH:
$984.15M
VRTX:
-$228.00M
LNTH:
$438.66M
Returns By Period
In the year-to-date period, VRTX achieves a 4.58% return, which is significantly higher than LNTH's -11.90% return.
VRTX
4.58%
-15.06%
-14.85%
-1.73%
7.88%
12.84%
LNTH
-11.90%
-22.83%
-1.19%
0.14%
46.10%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. LNTH — Risk-Adjusted Performance Rank
VRTX
LNTH
VRTX vs. LNTH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Lantheus Holdings, Inc. (LNTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VRTX vs. LNTH - Dividend Comparison
Neither VRTX nor LNTH has paid dividends to shareholders.
Drawdowns
VRTX vs. LNTH - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, which is greater than LNTH's maximum drawdown of -78.62%. Use the drawdown chart below to compare losses from any high point for VRTX and LNTH. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VRTX vs. LNTH - Volatility Comparison
The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 13.18%, while Lantheus Holdings, Inc. (LNTH) has a volatility of 27.44%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than LNTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VRTX vs. LNTH - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Lantheus Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRTX vs. LNTH - Profitability Comparison
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
LNTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported a gross profit of 237.70M and revenue of 372.76M. Therefore, the gross margin over that period was 63.8%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
LNTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported an operating income of 102.07M and revenue of 372.76M, resulting in an operating margin of 27.4%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.
LNTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported a net income of 72.95M and revenue of 372.76M, resulting in a net margin of 19.6%.